HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-JUL-15 5AX9 TITLE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- TITLE 2 INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRAF2 AND NCK-INTERACTING PROTEIN KINASE; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 2.7.11.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNIK, KIAA0551; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS INHIBITOR, KINASE, COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.OHBAYASHI,M.KUKIMOTO-NIINO,T.YAMADA,M.SHIROUZU REVDAT 4 08-NOV-23 5AX9 1 REMARK REVDAT 3 26-FEB-20 5AX9 1 REMARK REVDAT 2 07-SEP-16 5AX9 1 JRNL REVDAT 1 27-JUL-16 5AX9 0 JRNL AUTH M.MASUDA,Y.UNO,N.OHBAYASHI,H.OHATA,A.MIMATA, JRNL AUTH 2 M.KUKIMOTO-NIINO,H.MORIYAMA,S.KASHIMOTO,T.INOUE,N.GOTO, JRNL AUTH 3 K.OKAMOTO,M.SHIROUZU,M.SAWA,T.YAMADA JRNL TITL TNIK INHIBITION ABROGATES COLORECTAL CANCER STEMNESS JRNL REF NAT COMMUN V. 7 12586 2016 JRNL REFN ESSN 2041-1723 JRNL PMID 27562646 JRNL DOI 10.1038/NCOMMS12586 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 36883 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1851 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5481 - 5.6405 1.00 2906 162 0.2016 0.2728 REMARK 3 2 5.6405 - 4.4780 1.00 2741 156 0.1797 0.2383 REMARK 3 3 4.4780 - 3.9123 1.00 2711 134 0.1756 0.2126 REMARK 3 4 3.9123 - 3.5547 1.00 2697 161 0.1848 0.2417 REMARK 3 5 3.5547 - 3.3000 1.00 2677 146 0.2023 0.3021 REMARK 3 6 3.3000 - 3.1054 1.00 2676 137 0.2178 0.2770 REMARK 3 7 3.1054 - 2.9499 1.00 2657 137 0.2250 0.3276 REMARK 3 8 2.9499 - 2.8215 1.00 2702 128 0.2358 0.3049 REMARK 3 9 2.8215 - 2.7129 1.00 2671 146 0.2350 0.3079 REMARK 3 10 2.7129 - 2.6193 1.00 2618 142 0.2296 0.3199 REMARK 3 11 2.6193 - 2.5374 1.00 2665 134 0.2366 0.3401 REMARK 3 12 2.5374 - 2.4649 1.00 2655 136 0.2391 0.2798 REMARK 3 13 2.4649 - 2.4000 1.00 2656 132 0.2546 0.3558 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 6969 REMARK 3 ANGLE : 0.982 9407 REMARK 3 CHIRALITY : 0.039 1007 REMARK 3 PLANARITY : 0.005 1199 REMARK 3 DIHEDRAL : 15.222 2629 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SF FILE CONTAINS FRIEDEL PAIRS UNDER REMARK 3 I/F_MINUS AND I/F_PLUS COLUMNS. REMARK 4 REMARK 4 5AX9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1300000121. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36951 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 48.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2X7F REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN F_PLUS/MINUS COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG3350, 0.2M AMMONIUM SULFATE, REMARK 280 0.1M BIS-TRIS (5.6), PH 5.6, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.60200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.82600 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.60200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 78.82600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 ALA A 10 REMARK 465 ASP A 11 REMARK 465 ALA A 176 REMARK 465 GLN A 177 REMARK 465 LEU A 178 REMARK 465 ASP A 179 REMARK 465 ARG A 180 REMARK 465 THR A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ARG A 184 REMARK 465 ARG A 185 REMARK 465 ASN A 186 REMARK 465 THR A 187 REMARK 465 PHE A 188 REMARK 465 ILE A 189 REMARK 465 ARG A 308 REMARK 465 THR A 309 REMARK 465 LYS A 310 REMARK 465 LYS A 311 REMARK 465 LYS A 312 REMARK 465 ARG A 313 REMARK 465 GLY A 314 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 GLY B 9 REMARK 465 ALA B 10 REMARK 465 ASP B 11 REMARK 465 GLU B 12 REMARK 465 GLN B 177 REMARK 465 LEU B 178 REMARK 465 ASP B 179 REMARK 465 ARG B 180 REMARK 465 THR B 181 REMARK 465 VAL B 182 REMARK 465 GLY B 183 REMARK 465 ARG B 184 REMARK 465 ARG B 185 REMARK 465 ASN B 186 REMARK 465 THR B 187 REMARK 465 PHE B 188 REMARK 465 CYS B 202 REMARK 465 ASP B 203 REMARK 465 GLU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 ASP B 207 REMARK 465 ALA B 208 REMARK 465 THR B 209 REMARK 465 TYR B 210 REMARK 465 ARG B 308 REMARK 465 THR B 309 REMARK 465 LYS B 310 REMARK 465 LYS B 311 REMARK 465 LYS B 312 REMARK 465 ARG B 313 REMARK 465 GLY B 314 REMARK 465 GLY C 7 REMARK 465 SER C 8 REMARK 465 GLY C 9 REMARK 465 ALA C 10 REMARK 465 ASP C 11 REMARK 465 LEU C 178 REMARK 465 ASP C 179 REMARK 465 ARG C 180 REMARK 465 THR C 181 REMARK 465 VAL C 182 REMARK 465 GLY C 183 REMARK 465 ARG C 184 REMARK 465 ARG C 185 REMARK 465 ASN C 186 REMARK 465 THR C 187 REMARK 465 PHE C 188 REMARK 465 ILE C 189 REMARK 465 ASP C 203 REMARK 465 GLU C 204 REMARK 465 ASN C 205 REMARK 465 PRO C 206 REMARK 465 LYS C 310 REMARK 465 LYS C 311 REMARK 465 LYS C 312 REMARK 465 ARG C 313 REMARK 465 GLY C 314 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU B 73 OG SER B 77 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP A 98 OH TYR C 40 3544 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 62 CB GLU B 62 CG -0.124 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 240 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 24 -60.87 -102.43 REMARK 500 VAL A 28 -60.34 -100.54 REMARK 500 ASP A 61 -70.34 -59.16 REMARK 500 HIS A 79 131.91 -170.40 REMARK 500 ASN A 93 120.89 -173.10 REMARK 500 ARG A 152 -13.90 79.64 REMARK 500 ASP A 171 86.00 62.88 REMARK 500 ASP A 207 65.35 -104.99 REMARK 500 LEU A 270 48.23 -99.45 REMARK 500 TYR B 36 18.10 85.34 REMARK 500 THR B 59 -156.54 -79.52 REMARK 500 PRO B 94 152.41 -46.32 REMARK 500 ASP B 153 41.96 -143.31 REMARK 500 ASP B 171 91.56 66.99 REMARK 500 PRO B 238 -48.60 -29.58 REMARK 500 ASN B 294 68.58 74.62 REMARK 500 ILE C 24 -61.76 -106.57 REMARK 500 TYR C 36 78.33 47.93 REMARK 500 THR C 59 -159.77 -110.16 REMARK 500 ARG C 152 -5.67 68.55 REMARK 500 ASP C 171 91.57 62.61 REMARK 500 THR C 191 74.45 50.85 REMARK 500 ASP C 235 45.13 -83.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4KT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4KT B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4KT C 401 DBREF 5AX9 A 11 314 UNP Q9UKE5 TNIK_HUMAN 11 314 DBREF 5AX9 B 11 314 UNP Q9UKE5 TNIK_HUMAN 11 314 DBREF 5AX9 C 11 314 UNP Q9UKE5 TNIK_HUMAN 11 314 SEQADV 5AX9 GLY A 7 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 SER A 8 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 GLY A 9 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 ALA A 10 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 GLY B 7 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 SER B 8 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 GLY B 9 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 ALA B 10 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 GLY C 7 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 SER C 8 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 GLY C 9 UNP Q9UKE5 EXPRESSION TAG SEQADV 5AX9 ALA C 10 UNP Q9UKE5 EXPRESSION TAG SEQRES 1 A 308 GLY SER GLY ALA ASP GLU ILE ASP LEU SER ALA LEU ARG SEQRES 2 A 308 ASP PRO ALA GLY ILE PHE GLU LEU VAL GLU LEU VAL GLY SEQRES 3 A 308 ASN GLY THR TYR GLY GLN VAL TYR LYS GLY ARG HIS VAL SEQRES 4 A 308 LYS THR GLY GLN LEU ALA ALA ILE LYS VAL MET ASP VAL SEQRES 5 A 308 THR GLY ASP GLU GLU GLU GLU ILE LYS GLN GLU ILE ASN SEQRES 6 A 308 MET LEU LYS LYS TYR SER HIS HIS ARG ASN ILE ALA THR SEQRES 7 A 308 TYR TYR GLY ALA PHE ILE LYS LYS ASN PRO PRO GLY MET SEQRES 8 A 308 ASP ASP GLN LEU TRP LEU VAL MET GLU PHE CYS GLY ALA SEQRES 9 A 308 GLY SER VAL THR ASP LEU ILE LYS ASN THR LYS GLY ASN SEQRES 10 A 308 THR LEU LYS GLU GLU TRP ILE ALA TYR ILE CYS ARG GLU SEQRES 11 A 308 ILE LEU ARG GLY LEU SER HIS LEU HIS GLN HIS LYS VAL SEQRES 12 A 308 ILE HIS ARG ASP ILE LYS GLY GLN ASN VAL LEU LEU THR SEQRES 13 A 308 GLU ASN ALA GLU VAL LYS LEU VAL ASP PHE GLY VAL SER SEQRES 14 A 308 ALA GLN LEU ASP ARG THR VAL GLY ARG ARG ASN THR PHE SEQRES 15 A 308 ILE GLY THR PRO TYR TRP MET ALA PRO GLU VAL ILE ALA SEQRES 16 A 308 CYS ASP GLU ASN PRO ASP ALA THR TYR ASP PHE LYS SER SEQRES 17 A 308 ASP LEU TRP SER LEU GLY ILE THR ALA ILE GLU MET ALA SEQRES 18 A 308 GLU GLY ALA PRO PRO LEU CYS ASP MET HIS PRO MET ARG SEQRES 19 A 308 ALA LEU PHE LEU ILE PRO ARG ASN PRO ALA PRO ARG LEU SEQRES 20 A 308 LYS SER LYS LYS TRP SER LYS LYS PHE GLN SER PHE ILE SEQRES 21 A 308 GLU SER CYS LEU VAL LYS ASN HIS SER GLN ARG PRO ALA SEQRES 22 A 308 THR GLU GLN LEU MET LYS HIS PRO PHE ILE ARG ASP GLN SEQRES 23 A 308 PRO ASN GLU ARG GLN VAL ARG ILE GLN LEU LYS ASP HIS SEQRES 24 A 308 ILE ASP ARG THR LYS LYS LYS ARG GLY SEQRES 1 B 308 GLY SER GLY ALA ASP GLU ILE ASP LEU SER ALA LEU ARG SEQRES 2 B 308 ASP PRO ALA GLY ILE PHE GLU LEU VAL GLU LEU VAL GLY SEQRES 3 B 308 ASN GLY THR TYR GLY GLN VAL TYR LYS GLY ARG HIS VAL SEQRES 4 B 308 LYS THR GLY GLN LEU ALA ALA ILE LYS VAL MET ASP VAL SEQRES 5 B 308 THR GLY ASP GLU GLU GLU GLU ILE LYS GLN GLU ILE ASN SEQRES 6 B 308 MET LEU LYS LYS TYR SER HIS HIS ARG ASN ILE ALA THR SEQRES 7 B 308 TYR TYR GLY ALA PHE ILE LYS LYS ASN PRO PRO GLY MET SEQRES 8 B 308 ASP ASP GLN LEU TRP LEU VAL MET GLU PHE CYS GLY ALA SEQRES 9 B 308 GLY SER VAL THR ASP LEU ILE LYS ASN THR LYS GLY ASN SEQRES 10 B 308 THR LEU LYS GLU GLU TRP ILE ALA TYR ILE CYS ARG GLU SEQRES 11 B 308 ILE LEU ARG GLY LEU SER HIS LEU HIS GLN HIS LYS VAL SEQRES 12 B 308 ILE HIS ARG ASP ILE LYS GLY GLN ASN VAL LEU LEU THR SEQRES 13 B 308 GLU ASN ALA GLU VAL LYS LEU VAL ASP PHE GLY VAL SER SEQRES 14 B 308 ALA GLN LEU ASP ARG THR VAL GLY ARG ARG ASN THR PHE SEQRES 15 B 308 ILE GLY THR PRO TYR TRP MET ALA PRO GLU VAL ILE ALA SEQRES 16 B 308 CYS ASP GLU ASN PRO ASP ALA THR TYR ASP PHE LYS SER SEQRES 17 B 308 ASP LEU TRP SER LEU GLY ILE THR ALA ILE GLU MET ALA SEQRES 18 B 308 GLU GLY ALA PRO PRO LEU CYS ASP MET HIS PRO MET ARG SEQRES 19 B 308 ALA LEU PHE LEU ILE PRO ARG ASN PRO ALA PRO ARG LEU SEQRES 20 B 308 LYS SER LYS LYS TRP SER LYS LYS PHE GLN SER PHE ILE SEQRES 21 B 308 GLU SER CYS LEU VAL LYS ASN HIS SER GLN ARG PRO ALA SEQRES 22 B 308 THR GLU GLN LEU MET LYS HIS PRO PHE ILE ARG ASP GLN SEQRES 23 B 308 PRO ASN GLU ARG GLN VAL ARG ILE GLN LEU LYS ASP HIS SEQRES 24 B 308 ILE ASP ARG THR LYS LYS LYS ARG GLY SEQRES 1 C 308 GLY SER GLY ALA ASP GLU ILE ASP LEU SER ALA LEU ARG SEQRES 2 C 308 ASP PRO ALA GLY ILE PHE GLU LEU VAL GLU LEU VAL GLY SEQRES 3 C 308 ASN GLY THR TYR GLY GLN VAL TYR LYS GLY ARG HIS VAL SEQRES 4 C 308 LYS THR GLY GLN LEU ALA ALA ILE LYS VAL MET ASP VAL SEQRES 5 C 308 THR GLY ASP GLU GLU GLU GLU ILE LYS GLN GLU ILE ASN SEQRES 6 C 308 MET LEU LYS LYS TYR SER HIS HIS ARG ASN ILE ALA THR SEQRES 7 C 308 TYR TYR GLY ALA PHE ILE LYS LYS ASN PRO PRO GLY MET SEQRES 8 C 308 ASP ASP GLN LEU TRP LEU VAL MET GLU PHE CYS GLY ALA SEQRES 9 C 308 GLY SER VAL THR ASP LEU ILE LYS ASN THR LYS GLY ASN SEQRES 10 C 308 THR LEU LYS GLU GLU TRP ILE ALA TYR ILE CYS ARG GLU SEQRES 11 C 308 ILE LEU ARG GLY LEU SER HIS LEU HIS GLN HIS LYS VAL SEQRES 12 C 308 ILE HIS ARG ASP ILE LYS GLY GLN ASN VAL LEU LEU THR SEQRES 13 C 308 GLU ASN ALA GLU VAL LYS LEU VAL ASP PHE GLY VAL SER SEQRES 14 C 308 ALA GLN LEU ASP ARG THR VAL GLY ARG ARG ASN THR PHE SEQRES 15 C 308 ILE GLY THR PRO TYR TRP MET ALA PRO GLU VAL ILE ALA SEQRES 16 C 308 CYS ASP GLU ASN PRO ASP ALA THR TYR ASP PHE LYS SER SEQRES 17 C 308 ASP LEU TRP SER LEU GLY ILE THR ALA ILE GLU MET ALA SEQRES 18 C 308 GLU GLY ALA PRO PRO LEU CYS ASP MET HIS PRO MET ARG SEQRES 19 C 308 ALA LEU PHE LEU ILE PRO ARG ASN PRO ALA PRO ARG LEU SEQRES 20 C 308 LYS SER LYS LYS TRP SER LYS LYS PHE GLN SER PHE ILE SEQRES 21 C 308 GLU SER CYS LEU VAL LYS ASN HIS SER GLN ARG PRO ALA SEQRES 22 C 308 THR GLU GLN LEU MET LYS HIS PRO PHE ILE ARG ASP GLN SEQRES 23 C 308 PRO ASN GLU ARG GLN VAL ARG ILE GLN LEU LYS ASP HIS SEQRES 24 C 308 ILE ASP ARG THR LYS LYS LYS ARG GLY HET 4KT A 401 31 HET SO4 A 402 5 HET 4KT B 401 31 HET SO4 B 402 5 HET 4KT C 401 31 HETNAM 4KT 4-METHOXY-3-[2-[(3-METHOXY-4-MORPHOLIN-4-YL-PHENYL) HETNAM 2 4KT AMINO]PYRIDIN-4-YL]BENZENECARBONITRILE HETNAM SO4 SULFATE ION FORMUL 4 4KT 3(C24 H24 N4 O3) FORMUL 5 SO4 2(O4 S 2-) FORMUL 9 HOH *107(H2 O) HELIX 1 AA1 ASP A 14 LEU A 18 5 5 HELIX 2 AA2 GLU A 62 SER A 77 1 16 HELIX 3 AA3 VAL A 113 ASN A 119 1 7 HELIX 4 AA4 THR A 120 THR A 124 5 5 HELIX 5 AA5 LYS A 126 HIS A 147 1 22 HELIX 6 AA6 LYS A 155 GLN A 157 5 3 HELIX 7 AA7 ALA A 196 ILE A 200 5 5 HELIX 8 AA8 ASP A 211 GLY A 229 1 19 HELIX 9 AA9 HIS A 237 ASN A 248 1 12 HELIX 10 AB1 SER A 259 LEU A 270 1 12 HELIX 11 AB2 ASN A 273 ARG A 277 5 5 HELIX 12 AB3 ALA A 279 MET A 284 1 6 HELIX 13 AB4 HIS A 286 ASP A 291 1 6 HELIX 14 AB5 ASN A 294 ASP A 307 1 14 HELIX 15 AB6 ASP B 14 LEU B 18 5 5 HELIX 16 AB7 GLU B 62 SER B 77 1 16 HELIX 17 AB8 VAL B 113 ASN B 119 1 7 HELIX 18 AB9 LYS B 126 HIS B 147 1 22 HELIX 19 AC1 LYS B 155 GLN B 157 5 3 HELIX 20 AC2 THR B 191 MET B 195 5 5 HELIX 21 AC3 LYS B 213 GLY B 229 1 17 HELIX 22 AC4 HIS B 237 ILE B 245 1 9 HELIX 23 AC5 SER B 259 LEU B 270 1 12 HELIX 24 AC6 ALA B 279 MET B 284 1 6 HELIX 25 AC7 HIS B 286 ASP B 291 1 6 HELIX 26 AC8 GLU B 295 ASP B 307 1 13 HELIX 27 AC9 ASP C 14 LEU C 18 5 5 HELIX 28 AD1 GLU C 62 SER C 77 1 16 HELIX 29 AD2 VAL C 113 ASN C 119 1 7 HELIX 30 AD3 LYS C 126 HIS C 147 1 22 HELIX 31 AD4 LYS C 155 GLN C 157 5 3 HELIX 32 AD5 ASP C 211 GLY C 229 1 19 HELIX 33 AD6 HIS C 237 ASN C 248 1 12 HELIX 34 AD7 SER C 259 LEU C 270 1 12 HELIX 35 AD8 ALA C 279 LYS C 285 1 7 HELIX 36 AD9 HIS C 286 ASP C 291 1 6 HELIX 37 AE1 ASN C 294 ARG C 308 1 15 SHEET 1 AA1 5 PHE A 25 GLY A 34 0 SHEET 2 AA1 5 GLY A 37 HIS A 44 -1 O GLY A 37 N GLY A 34 SHEET 3 AA1 5 LEU A 50 VAL A 58 -1 O ALA A 51 N GLY A 42 SHEET 4 AA1 5 ASP A 99 GLU A 106 -1 O MET A 105 N ALA A 52 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N TYR A 86 O VAL A 104 SHEET 1 AA2 3 GLY A 111 SER A 112 0 SHEET 2 AA2 3 VAL A 159 LEU A 161 -1 O LEU A 161 N GLY A 111 SHEET 3 AA2 3 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 AA3 5 PHE B 25 GLY B 34 0 SHEET 2 AA3 5 GLY B 37 HIS B 44 -1 O LYS B 41 N GLU B 29 SHEET 3 AA3 5 LEU B 50 VAL B 58 -1 O ILE B 53 N TYR B 40 SHEET 4 AA3 5 ASP B 99 MET B 105 -1 O LEU B 101 N MET B 56 SHEET 5 AA3 5 TYR B 85 LYS B 91 -1 N PHE B 89 O TRP B 102 SHEET 1 AA4 3 GLY B 111 SER B 112 0 SHEET 2 AA4 3 VAL B 159 LEU B 161 -1 O LEU B 161 N GLY B 111 SHEET 3 AA4 3 VAL B 167 LEU B 169 -1 O LYS B 168 N LEU B 160 SHEET 1 AA5 5 PHE C 25 GLY C 34 0 SHEET 2 AA5 5 GLY C 37 HIS C 44 -1 O ARG C 43 N GLU C 26 SHEET 3 AA5 5 LEU C 50 VAL C 58 -1 O ALA C 51 N GLY C 42 SHEET 4 AA5 5 ASP C 99 GLU C 106 -1 O LEU C 103 N LYS C 54 SHEET 5 AA5 5 TYR C 85 LYS C 91 -1 N TYR C 86 O VAL C 104 SHEET 1 AA6 3 GLY C 111 SER C 112 0 SHEET 2 AA6 3 VAL C 159 LEU C 161 -1 O LEU C 161 N GLY C 111 SHEET 3 AA6 3 VAL C 167 LEU C 169 -1 O LYS C 168 N LEU C 160 CISPEP 1 PRO A 95 GLY A 96 0 0.03 SITE 1 AC1 11 VAL A 31 ALA A 52 LYS A 54 GLU A 106 SITE 2 AC1 11 PHE A 107 CYS A 108 GLY A 109 ASP A 115 SITE 3 AC1 11 LEU A 160 VAL A 170 ASP A 171 SITE 1 AC2 2 ASP A 20 ARG B 247 SITE 1 AC3 13 VAL B 31 VAL B 39 ALA B 52 LYS B 54 SITE 2 AC3 13 MET B 105 GLU B 106 PHE B 107 CYS B 108 SITE 3 AC3 13 GLY B 109 ASP B 115 GLN B 157 LEU B 160 SITE 4 AC3 13 ASP B 171 SITE 1 AC4 3 ARG B 19 ASP B 20 LYS B 92 SITE 1 AC5 13 VAL C 31 VAL C 39 ALA C 52 LYS C 54 SITE 2 AC5 13 GLU C 106 PHE C 107 CYS C 108 GLY C 109 SITE 3 AC5 13 ASP C 115 GLN C 157 LEU C 160 VAL C 170 SITE 4 AC5 13 ASP C 171 CRYST1 47.178 123.204 157.652 90.00 90.00 90.00 P 2 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021196 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008117 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006343 0.00000